Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1010669403283
Reference17 articles.
1. Corry JFG, Lønning PE: Systematic therapy in breast cancer: efficacy and cost utility. Pharmacoeconomics 5: 198-212, 1994
2. Jordan VC: Tamoxifen for breast cancer prevention. Proc Soc Exp Biol Med 208: 144-149, 1995
3. Early Breast Cancer Trialists' Research Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1-15, 1992
4. Anderson EDC, Forrest APM, Levack PA, Chetty U, Hawkins RA: Response to endocrine manipulation and oestrogen receptor concentration in large, operable breast cancer. Br J Cancer 60: 223-226, 1989
5. Hamilton A, Piccart M: The third generation nonsteroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer. Ann Oncol 10: 377-384, 1999
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer;Expert Review of Anticancer Therapy;2023-01-02
2. The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study;Current Oncology;2022-03-23
3. Predictor for supraphysiologic serum estradiol elevation on hCG triggering day of controlled ovarian stimulation using letrozole and gonadotropins in women with estrogen-dependent cancers;PLOS ONE;2020-10-21
4. The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer;Annals of Surgical Oncology;2020-06-26
5. Separate quantification of anastrozole and letrozole by a novel stability‐indicating ultra‐fast LC method;SEPARATION SCIENCE PLUS;2020-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3